Препринт

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. PageCollaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaJoanne E. McKenzie. School of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaPatrick M. Bossuyt. Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, NetherlandsIsabelle Boutron. Universit de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004 Paris, FranceTammy Hoffmann. Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australiacindy mulrow. University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States;Larissa Shamseer. School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, CanadaJennifer TetzlaffCollaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaElie A. Akl. Clinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact,Sue BrennanSchool of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria, 3004, AustraliaRoger Chou. Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, United StatesJulie GlanvilleCollaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaJeremy GrimshawUniversity of Ottawa, Ottawa, Canada; Department of Medicine,Asbjørn HróbjartssonDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient data Explorative Network,Manoj M. LaluCollaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaTianjing Li. Department of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United States; Department of Epidemiology,Elizabeth Loder. Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States;Evan Mayo‐WilsonSchool of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria, 3004, AustraliaSteve McDonald. Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, United StatesLuke A. McGuinness. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKLesley StewartCollaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaJames Thomas. Centre for Reviews and Dissemination, University of York, York, UKAndrea C. TriccoCollaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaVivian Welch. Li Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, Toronto, Canada;Penny Whiting. Methods Centre, Bruyre Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine,David Moher. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK

2020en

ABI

Аннотация

Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did and what they found. Over the last decade, there have been many advances in systematic review methodology and terminology, which have necessitated an update to the guideline.Objectives: To develop the PRISMA 2020 statement for reporting systematic reviews.Methods: We reviewed 60 documents with reporting guidance for systematic reviews to generate suggested modifications to the PRISMA 2009 statement. We sought feedback on the suggested modifications through an online survey of 110 systematic review methodologists and journal editors. The results of the review and survey were discussed at a 21-member in-person meeting. Following the meeting, drafts of the PRISMA 2020 checklist, abstract checklist, explanation and elaboration and flow diagram were generated and refined iteratively based on feedback from co-authors and a convenience sample of 15 systematic reviewers.Results: In this statement paper, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. The checklist includes new reporting guidance that reflects advances in methods to identify, select, appraise and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. The PRISMA 2020 statement replaces the 2009 statement.Conclusions: The PRISMA 2020 statement is intended to facilitate transparent, complete and accurate reporting of systematic reviews. Improved reporting should benefit users of reviews, including guideline developers, policy makers, health care providers, patients and other stakeholders. In order to achieve this, we encourage authors, editors and peer-reviewers to adopt the guideline.

Перевод пока недоступен

Идентификаторы

DOI: 10.31222/osf.io/v7gm2

Цитирования и источники

Цитирований: 2Использованных источников: 0

Показатели — AkademScholar